- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NSCLC (Non-small Cell Lung Carcinoma)
Total 7943 results
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Canada, France, Singapore, Taiwan
-
Fatebenefratelli and Ophthalmic HospitalNiguarda Hospital; Mario Negri Institute for Pharmacological ResearchUnknown
-
NovoCure Ltd.CompletedNSCLC | Non-small Cell Lung CancerSwitzerland
-
Simcere Pharmaceutical Co., LtdUnknownNon-small Cell Lung Cancer (NSCLC)China
-
National Cancer Institute (NCI)Completed
-
Hadassah Medical OrganizationUnknown
-
Henan Cancer HospitalNot yet recruitingNon-Small Cell Lung Cancer NSCLC
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Jinming YuRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
Pingping SongNot yet recruitingNon-Small Cell Lung Cancer(NSCLC)China
-
Jinming YuRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
Shanghai Miracogen Inc.Not yet recruitingNon-small- Cell Lung Cancer (NSCLC)China
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
Albert Einstein College of MedicineCelldex TherapeuticsActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
BeiGeneActive, not recruitingNSCLC | Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
-
Novartis PharmaceuticalsActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)China
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Abramson Cancer Center at Penn MedicineCompletedOligometastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Incyte CorporationCompletedNon-Small Cell Lung Cancer (NSCLC)Spain, United States, Italy, Germany, France
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Spain
-
G1 Therapeutics, Inc.TerminatedNSCLC | Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
Daiichi Sankyo, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)Taiwan
-
Hoffmann-La RocheWithdrawn
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
AstraZenecaCompleted
-
CelgeneCompletedNon-Small Cell Lung Cancer (NSCLC)Russian Federation
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Theresa Whiteside, PhDImmune Cell Therapy Inc.TerminatedNon Small Cell Lung Cancer (NSCLC)United States
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Recombio SLEurofarma Laboratorios S.A.; Laboratorio Elea Phoenix S.A.; Innogene Kalbiotech... and other collaboratorsUnknownNSCLC | Lung Cancer, Non-small CellBrazil, Indonesia, Argentina, Cuba, Philippines, Singapore, Thailand
-
TTY BiopharmCompletedNon-small-cell Lung Cancer (NSCLC)Taiwan
-
AbbVie (prior sponsor, Abbott)CompletedNSCLC | Lung Cancer | Non-Small-Cell Lung CancerUnited States, Czech Republic, Greece, Hungary, Netherlands, Slovakia
-
National Taiwan University HospitalUnknownNon-small Cell Lung Cancer (NSCLC)Taiwan
-
PfizerTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Genzyme, a Sanofi CompanyCompleted
-
Julia K. Rotow, MDInivataActive, not recruitingMetastatic Non-Small Cell Lung Cancer | NSCLC Stage IVUnited States
-
Chao HuangUniversity of Kansas Medical CenterActive, not recruitingAdvanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC)United States
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
Kyowa Kirin Korea Co., Ltd.TerminatedPhase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma | Phase 2 Portion : Small Cell Lung Cancer(SCLC)Korea, Republic of
-
Jeffrey ClarkeMerck Sharp & Dohme LLC; Grid TherapeuticsSuspendedNon Small Cell Lung Cancer | Metastatic NSCLC | Recurrent Non Small Cell Lung CancerUnited States
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina